A Challenging Case of Carcinoid Crisis in a Patient With Neuroendocrine Tumor

被引:1
作者
Mahdi, Mohammed [1 ]
Ozer, Muhammet [1 ]
Tahseen, Muhammad [2 ]
机构
[1] Capital Hlth Syst, Internal Med, Trenton, NJ 08638 USA
[2] Capital Hlth Syst, Crit Care Med, Trenton, NJ USA
关键词
carcinoid crisis; neuroendocrine tumor; octreotide; hypotension; shock; COMPLICATIONS; OCTREOTIDE; BOLUS;
D O I
10.7759/cureus.15626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The critical state of circulatory collapse and hypoperfusion that results in end-organ damage has been called shock. Carcinoid crisis is a rare cause of shock, which is difficult to identify in the presence of infection. It occurs due to the release of vasoactive amines into the systemic circulation following an inciting event. In the presence of a neuroendocrine tumor, carcinoid crisis should be suspected in case of resistant shock. Herein, we report a rare case of carcinoid crisis, in which a quick response to the somatostatin analog therapy, octreotide, was helpful to confirm the diagnosis.
引用
收藏
页数:5
相关论文
共 13 条
[1]   Carcinoid tumour [J].
Caplin, ME ;
Buscombe, JR ;
Hilson, AJ ;
Jones, AL ;
Watkinson, AF ;
Burroughs, AK .
LANCET, 1998, 352 (9130) :799-805
[2]   Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis [J].
Condron, Mary E. ;
Pommier, SuEllen J. ;
Pommier, Rodney F. .
SURGERY, 2016, 159 (01) :358-365
[3]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342
[4]   B-Adrenergic agonist administration is not associated with secondary carcinoid crisis in patients with carcinoid tumor [J].
Limbach, Kristen E. ;
Condron, Mary E. ;
Bingham, Ann E. ;
Pommier, SuEllen J. ;
Pommier, Rodney F. .
AMERICAN JOURNAL OF SURGERY, 2019, 217 (05) :932-936
[5]   The spectrum of carcinoid tumours and carcinoid syndromes [J].
Lips, CJM ;
Lentjes, EGWM ;
Höppener, JWM .
ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 :612-627
[6]   Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients [J].
Massimino, Kristen ;
Harrskog, Ola ;
Pommier, Suellen ;
Pommier, Rodney .
JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (08) :842-846
[7]   Current status of gastrointestinal carcinoids [J].
Modlin, IM ;
Kidd, M ;
Latich, I ;
Zikusoka, MN ;
Shapiro, MD .
GASTROENTEROLOGY, 2005, 128 (06) :1717-1751
[8]   Complications from carcinoid syndrome: review of the current evidence [J].
Mota, Jose Mauricio ;
Sousa, Luana Guimaraes ;
Riechelmann, Rachel P. .
ECANCERMEDICALSCIENCE, 2016, 10
[9]   Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors [J].
Sansone, Andrea ;
Lauretta, Rosa ;
Vottari, Sebastiano ;
Ari, Alfonsina Chief ;
Barnabei, Agnese ;
Romanelli, Francesco ;
Appetecchia, Marialuisa .
CANCERS, 2019, 11 (08)
[10]  
Seymour N, 2013, CAN J ANESTH, V60, P492, DOI 10.1007/s12630-012-9879-1